Actively Recruiting

Age: 22Years +
All Genders
ID07045103

A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection

Led by Invenio Imaging Inc. · Updated on 2025-07-01

900

Participants Needed

7

Research Sites

4 weeks

Total Duration

On this page

Sponsors

I

Invenio Imaging Inc.

Lead Sponsor

M

Memorial Sloan Kettering Cancer Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate deep learning algorithms designed to detect suspicious cell and tissue patterns for cancer in biopsies taken from peripheral lung nodules, masses, and mediastinal or hilar lymph nodes. The study uses the NIO Laser Imaging System during bronchoscopy procedures to image samples without traditional processing. It is a prospective, observational study focusing on rapid lung cancer detection with artificial intelligence assistance. The study includes four groups based on biopsy location and method: transbronchial forceps biopsy of peripheral lung nodules/masses, transbronchial needle aspiration biopsy of peripheral lung nodules/masses, transbronchial needle aspiration biopsy of mediastinal/hilar lymph nodes, and transbronchial cryo biopsy of peripheral lung nodules/masses. Each biopsy procedure is performed as part of routine clinical care, and imaging is done in the procedure room using the NIO Laser Imaging System. Participants are adults scheduled for clinically indicated lung biopsies with an intermediate to high likelihood of lung cancer. The study tracks outcomes from enrollment until the end of each biopsy procedure. Researchers will assess how well the deep learning algorithms identify suspicious morphology during the procedure. Participants will be monitored during their procedures, and data will be collected to validate the technology's performance in detecting cancerous changes.

CONDITIONS

Brief Title

A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study

Who Can Participate

Age: 22Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient or legal guardian is willing and able to understand, sign, and date the informed consent form.
  • Patient is 22 years of age or older.
  • Patient is scheduled for routine mediastinal staging (EBUS-TBNA) and peripheral lung biopsy with intermediate to high suspicion of lung cancer.
  • Patient can tolerate the indicated clinical procedure.
Not Eligible

You will not qualify if you...

  • Patient is a prisoner.
  • Investigator judges the participant as inappropriate for the intended study procedures.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Day of the procedure

Participants undergo routine bronchoscopy procedures including mediastinal staging and peripheral lung biopsy to aid in lung cancer detection.

1 visit (in-person)

Trial Site Locations

Total: 7 locations

1

UC San Diego

San Diego, California, United States, 92037

Actively Recruiting

2

Mayo Clinic Jacksonville

Jacksonville, Florida, United States, 32224

Not Yet Recruiting

3

Corewell Health

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

4

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

Suspended

5

Montefiore Medical Center

The Bronx, New York, United States, 10467

Actively Recruiting

6

UNC Medical Center

Chapel Hill, North Carolina, United States, 27514

Actively Recruiting

7

MD Anderson Cancer Center

Houston, Texas, United States, 77030

Active, Not Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Robotic-Assisted Versus Conventional Bronchoscopy for Cryobi...

Interstitial Lung Disease (ILD)

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here